肾癌临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 肾癌（国际通用名 renal cell carcinoma）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肾细胞癌、肾脏肿瘤等说法。
正在招募的肾癌新药试验
Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy
不适用招募中中国NCT07141225Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
不适用招募中意大利NCT07299357Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
II 期招募中美国NCT06005818Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance
不适用招募中美国NCT07714018Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
II 期招募中美国NCT06376669Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
IV 期招募中美国NCT07405086Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
II 期招募中美国NCT04981509Renal Adjuvant MultiPle Arm Randomised Trial
III 期招募中英国NCT03288532A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
I 期 / II 期招募中美国澳大利亚加拿大德国NCT04895709Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
II 期招募中美国NCT07397611Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
II 期招募中中国NCT05768464A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
I 期招募中美国中国NCT06792552
肾癌试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。